| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 20 | +65.00% | +3.79% | +1.15% | +2.64% | -0.85% | — |
| 14d | 20 | +45.00% | +0.38% | +0.39% | -0.01% | -3.25% | — |
| 30d | 20 | +45.00% | +0.29% | +1.94% | -1.65% | -2.50% | — |
| 60d | 20 | +25.00% | -3.44% | +3.40% | -6.84% | -8.42% | — |
| 90d | 20 | +55.00% | -2.06% | +4.11% | -6.17% | -2.20% | — |
| 180d | 20(1 pending) | +57.89% | -8.73% | +10.02% | -18.74% | -10.64% | — |
| 1y | 20(4 pending) | +25.00% | -7.41% | +19.44% | -26.86% | -40.79% | — |
| 2y | 20(12 pending) | +37.50% | -17.73% | +33.97% | -51.70% | -68.89% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 471,698 | $26.50 | $12.50M | 4,977,089 | May 26, 2026 | May 27, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 3,739,000 | $0.53 | $2.00M | 40,384,266 | Feb 13, 2026 | Feb 17, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE | 13,335,000 | — | — | 0 | Nov 26, 2025 | Dec 1, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 13,335,000 | $0.75 | $10.00M | 36,645,266 | Nov 26, 2025 | Dec 1, 2025 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 1,147,960 | — | — | 1,147,960 | Aug 8, 2025 | Oct 3, 2025 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 1,147,960 | — | — | 1,147,960 | Aug 8, 2025 | Oct 3, 2025 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 2,295,920 | — | — | 4,505,391 | Aug 8, 2025 | Oct 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 13,335,000 | — | — | 23,310,266 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 13,335,000 | — | — | 13,335,000 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 13,335,000 | — | — | 13,335,000 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 13,335,000 | — | — | 13,335,000 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| RCUS ARCUS BIOSCIENCES, INC. | PURCHASE | 1,363,636 | $11.00 | $15.00M | 31,424,760 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 940,499 | $21.37 | $20.10M | 2,209,471 | Dec 19, 2024 | Dec 23, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 1,759,978 | $1.04 | $1.83M | 9,105,451 | Dec 18, 2024 | Dec 19, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 6,092,816 | $1.04 | $6.34M | 9,975,266 | Dec 18, 2024 | Dec 19, 2024 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 179,500 | — | — | 179,500 | Jun 17, 2024 | Jun 20, 2024 ↗ | View → |
| ASMB ASSEMBLY BIOSCIENCES, INC. | PURCHASE | 179,500 | — | — | 1,268,972 | Jun 17, 2024 | Jun 20, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 3,882,450 | $0.76 | $2.95M | 3,882,450 | Apr 2, 2024 | Apr 3, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 485,250 | $0.76 | $368.8K | 7,345,473 | Apr 2, 2024 | Apr 3, 2024 ↗ | View → |
| KYTX KYVERNA THERAPEUTICS, INC. | PURCHASE | 3,216,119 | — | — | 3,216,119 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| KYTX KYVERNA THERAPEUTICS, INC. | PURCHASE | 910,000 | $22.00 | $20.02M | 4,126,119 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| KYTX KYVERNA THERAPEUTICS, INC. | SALE | 6,890,744 | — | — | 0 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| KYTX KYVERNA THERAPEUTICS, INC. | SALE | 7,746,139 | — | — | 0 | Feb 12, 2024 | Feb 13, 2024 ↗ | View → |
| RCUS ARCUS BIOSCIENCES, INC. | PURCHASE | 15,238,095 | $21.00 | $320.00M | 30,061,124 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| RCUS ARCUS BIOSCIENCES, INC. | PURCHASE | 1,010,000 | $19.26 | $19.45M | 14,823,029 | Jun 28, 2023 | Jun 30, 2023 ↗ | View → |
| RCUS ARCUS BIOSCIENCES, INC. | PURCHASE | 5,650,000 | $39.00 | $220.35M | 13,913,029 | Jan 31, 2021 | Feb 2, 2021 ↗ | View → |